TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28641863

Group type: COMPARATOR
Intervention: Passive (survival jacket)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Active (7 min rewarm-up after 8 min rest)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Combined (7 min rewarm-up after 8 min wearing survival jacket)
Number of subjects: 20
Study: 27350654

Group type: EXPERIMENTAL
Intervention: Alcohol dependent participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-alcohol dependent participants
Number of subjects: 0
Study: 23775701

Group type: EXPERIMENTAL
Intervention: Osteo‐cise program (n=81)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (n=81)
Number of subjects: 162
Study: 22828718

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) initiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD4+ T-cell counts >500 cells/mm³
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIV-1 RNA >400 copies/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protease-inhibitor (PI)-based regimen
Number of subjects: 0
Study: 20084587

Group type: EXPERIMENTAL
Intervention: Stepping Stones Triple P
Number of subjects: 0
Study: 18050577

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (Group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite plus 17% EDTAC (Group 2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: EDTA gel combined with 5.25% sodium hypochlorite (Group 3)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel (Group 4)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite combined with Glyde File Prep gel (Group 5)
Number of subjects: 50
Study: 16085507

Group type: EXPERIMENTAL
Intervention: General portion snus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Catch Licorice portion snus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Catch Mini portion snus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Catch Dry Mini portion snus
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2-mg Nicorette gum
Number of subjects: 0
Study: 11966664

Group type: EXPERIMENTAL
Intervention: Intravenous M6G 2 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Subcutaneous M6G 2 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nebulized M6G 4 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral M6G 20 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous and subcutaneous M6G
Number of subjects: 10
Study: 10189144

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 1054

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Control (no calcium antagonist)
Number of subjects: 1054
Study: 7478029

Group type: EXPERIMENTAL
Intervention: Heparin/nitroglycerin infused in the same site
Number of subjects: 98

Group type: COMPARATOR
Intervention: Heparin/nitroglycerin infused in separate sites
Number of subjects: 98
Study: 1695225

Group type: EXPERIMENTAL
Intervention: Strict glycemic control
Number of subjects: 79

Group type: COMPARATOR
Intervention: Customary glycemic control
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nondiabetic pregnancies
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Diabetic subjects with pregestational hypertension or microvascular disease
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Diabetic subjects with pregnancy-induced hypertension
Number of subjects: 79
Study: 29982371

Group type: EXPERIMENTAL
Intervention: Functional appliance treatment for 12 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (age- and gender-matched children without immediate orthodontic treatment need)
Number of subjects: 20
Study: 27605591

Group type: EXPERIMENTAL
Intervention: Accu-Chek® FlexLink Plus (FL Plus)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Accu-Chek® FlexLink infusion set (FL)
Number of subjects: 80
Study: 25322972

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Music Medicine (MM)
Number of subjects: 31
Study: 23438045

Group type: EXPERIMENTAL
Intervention: Miconazole (MIC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ricinus communis (RC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nystatin (NYS)
Number of subjects: 30
Study: 21550483

Group type: EXPERIMENTAL
Intervention: Amoxicillin plus clavulanic acid (3 g per day for 8-15 days)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Emergency appendicectomy
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Amoxicillin plus clavulanic acid
Number of subjects: 239
Study: 20028307

Group type: EXPERIMENTAL
Intervention: Fast bandaid removal
Number of subjects: 65

Group type: COMPARATOR
Intervention: Slow bandaid removal
Number of subjects: 65
Study: 17061635

Group type: EXPERIMENTAL
Intervention: BIS 25
Number of subjects: 40

Group type: COMPARATOR
Intervention: BIS 40
Number of subjects: 40
Study: 15163472

Group type: EXPERIMENTAL
Intervention: Group II (30.5 g fiber, 4.11 g soluble fiber)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Group I (10.4 g fiber, 1.97 g soluble fiber)
Number of subjects: 53
Study: 11334767

Group type: EXPERIMENTAL
Intervention: CS-866
Number of subjects: 2145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2145
Study: 15321225

Group type: EXPERIMENTAL
Intervention: Epidural diamorphine 2.5 mg in 10 ml normal saline following spinal anaesthesia
Number of subjects: 58

Group type: COMPARATOR
Intervention: Epidural diamorphine 2.5 mg in 10 ml normal saline following conventional epidural anaesthesia
Number of subjects: 58
Study: 8165073

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin prophylaxis (once-daily dose)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 2832173

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg day-1 for 5 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Frusemide added to enalapril therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Frusemide alone (before enalapril)
Number of subjects: 12
Study: 29800122

Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention (n=19,541)
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Usual-diet comparison group (n=29,294)
Number of subjects: 48835
Study: 27942799

Group type: EXPERIMENTAL
Intervention: Light-intensity walking (LW): sitting plus 3 min bouts of light-intensity walking at 3.2 km/h every 30 min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Simple resistance activities (SRA): sitting plus 3 min bouts of simple resistance activities every 30 min
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prolonged sitting (SIT)
Number of subjects: 24
Study: 26156323

Group type: EXPERIMENTAL
Intervention: Community mobilization protocol
Number of subjects: 85182
Study: 22948783

Group type: EXPERIMENTAL
Intervention: Eggs on toast
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cereal (cornflakes) with milk and toast
Number of subjects: 30

Group type: COMPARATOR
Intervention: Croissant and orange juice
Number of subjects: 30
Study: 20860641

Group type: EXPERIMENTAL
Intervention: Acute secondhand smoke exposure (1 hour, mean fine particulate matter < 2.5 μm level = 315 ± 116 μg/m(3))
Number of subjects: 25
Study: 17851680

Group type: COMPARATOR
Intervention: Aqueous solution (AS)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Protein-rich food bar (PP)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Beta-glucan-rich food bar (BG)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: All forms of creatine ingestion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Creatine ingestion
Number of subjects: 17
Study: 16455626

Group type: COMPARATOR
Intervention: Presymptomatic HD subjects (n = 24)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Clinically unaffected subjects at risk for HD and symptomatic patients
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Longitudinal follow-up of HD subjects (n = 10)
Number of subjects: 71
Study: 14514236

Group type: EXPERIMENTAL
Intervention: Dental prophylaxis plus placebo capsule
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus placebo capsule
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus metronidazole capsule (250 mg t.i.d. for one week)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Untreated reference group (723 pregnant women with periodontitis)
Number of subjects: 366
Study: 10740958

Group type: EXPERIMENTAL
Intervention: Reasonable woman legal standard
Number of subjects: 200

Group type: COMPARATOR
Intervention: Reasonable person legal standard
Number of subjects: 200
Study: 8864710

Group type: EXPERIMENTAL
Intervention: Acyclovir (ACV) 4 g/day for at least a week
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 105
Study: 1497054

Group type: EXPERIMENTAL
Intervention: Danazol 400 mg/day for 4 months (n = 22)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hysterectomy (n = 20)
Number of subjects: 42
Study: 6342168

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol (0.25 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol (0.5 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous practolol (0.4 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (1 ml)
Number of subjects: 0
Study: 31874872

Group type: EXPERIMENTAL
Intervention: Patient feedback intervention using the PREOS‐PC survey
Number of subjects: 1248

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1248
Study: 30243898

Group type: EXPERIMENTAL
Intervention: Kettlebell training (KT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 33
Study: 27227930

Group type: EXPERIMENTAL
Intervention: Immunonutrition (immune-enhancing feed)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control supplement (hypercaloric hypernitrogenous supplement)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control supplement
Number of subjects: 264
Study: 24863086

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 21793707

Group type: EXPERIMENTAL
Intervention: Essential Newborn Care training
Number of subjects: 25096

Group type: COMPARATOR
Intervention: Neonatal resuscitation training
Number of subjects: 25096
Study: 20158293

Group type: EXPERIMENTAL
Intervention: Contingent intervention with vouchers based on breath carbon monoxide levels and urinary cotinine levels, with earnings starting at $9.00 and increasing by $1.50 for each negative sample, maximum possible of $362.50.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Noncontingent intervention with vouchers independent of smoking status.
Number of subjects: 40
Study: 19018906

Group type: EXPERIMENTAL
Intervention: Electronic information intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular medical intervention
Number of subjects: 0
Study: 16969618

Group type: EXPERIMENTAL
Intervention: Seprafilm under the midline incision and around the stoma (Group I)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Only under the midline incision (Group II)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Not to receive Seprafilm (Group III)
Number of subjects: 191
Study: 12680331

Group type: EXPERIMENTAL
Intervention: Azithromycin aspartic-acid injection (monotherapy, once-daily intravenous dosing)
Number of subjects: 19
Study: 10232636

Group type: EXPERIMENTAL
Intervention: Retinol (60 mg as retinyl palmitate)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Beta-carotene (7.6 mg daily)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo (daily)
Number of subjects: 212
Study: 8912406

Group type: EXPERIMENTAL
Intervention: d-fenfluramine (FEN) 15 mg, PO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: d-fenfluramine (FEN) 30 mg, PO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: d-fenfluramine (FEN)
Number of subjects: 0
Study: 1886022

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate rinse
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 139
Study: 6340917

Group type: EXPERIMENTAL
Intervention: Ambulant
Number of subjects: 119

Group type: COMPARATOR
Intervention: Bed rest for 24 hours
Number of subjects: 119
Study: 29543617

Group type: EXPERIMENTAL
Intervention: IDHF‐001
Number of subjects: 91

Group type: COMPARATOR
Intervention: Restylane SubQ
Number of subjects: 91
Study: 28398947

Group type: EXPERIMENTAL
Intervention: 0.15 g·kg of body mass of ammonium chloride (NH4Cl, acidosis)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 0.3 g·kg of sodium bicarbonate (NaHCO3, alkalosis)
Number of subjects: 11

Group type: COMPARATOR
Intervention: 0.15 g·kg of CaCO3 (placebo)
Number of subjects: 11
Study: 25449195

Group type: EXPERIMENTAL
Intervention: FES-assisted active cycling
Number of subjects: 40

Group type: COMPARATOR
Intervention: Active cycling without FES (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (FES and Control)
Number of subjects: 40
Study: 23791495

Group type: EXPERIMENTAL
Intervention: 5mg of morphine sulfate intramuscularly
Number of subjects: 53

Group type: COMPARATOR
Intervention: 5mg of haloperidol intramuscularly
Number of subjects: 53
Study: 21205123

Group type: EXPERIMENTAL
Intervention: IDet + SITA + MET
Number of subjects: 0

Group type: COMPARATOR
Intervention: SITA + MET ± SU
Number of subjects: 0
Study: 19083486

Group type: EXPERIMENTAL
Intervention: Medical nutrition therapy (MNT) emphasizing dietary folate intake, performed 5 times during the 12 weeks of the experiment.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Medical nutrition therapy (MNT) emphasizing dietary folate intake.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study: 16545010

Group type: EXPERIMENTAL
Intervention: Enfuvirtide (ENF) + optimized background (OB) therapy
Number of subjects: 2

Group type: COMPARATOR
Intervention: Optimized background (OB) therapy
Number of subjects: 2
Study: 12956656

Group type: EXPERIMENTAL
Intervention: Toothpaste A
Number of subjects: 15

Group type: COMPARATOR
Intervention: Toothpaste B
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 15

Group type: COMPARATOR
Intervention: Drinking water
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Orange juice and Toothpaste A
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Orange juice and Toothpaste B
Number of subjects: 15
Study: 11369148

Group type: COMPARATOR
Intervention: EC model leaflet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mark II leaflet
Number of subjects: 20
Study: 9407172

Group type: EXPERIMENTAL
Intervention: Topical melatonin (0.6 mg/cm2) applied 15 min before UV irradiation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical melatonin (0.6 mg/cm2) applied 1, 30, or 240 min after UV irradiation
Number of subjects: 20
Study: 8269792

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 16
Study: 3730239

Group type: EXPERIMENTAL
Intervention: Cricoid pressure using the cricoid yoke device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard practice without the cricoid yoke)
Number of subjects: 0
Study: 29128440

Group type: EXPERIMENTAL
Intervention: McCall culdoplasty followed by standard cuff closure
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard cuff closure
Number of subjects: 50
Study: 27565224

Group type: EXPERIMENTAL
Intervention: OPC‐1085EL (n=118)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Latanoprost (n=119)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: OPC‐1085EL (n=78)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Carteolol (n=78)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Carteolol/latanoprost concomitant therapy (n=37)
Number of subjects: 430
Study: 24764186

Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine (TAPB)
Number of subjects: 83

Group type: COMPARATOR
Intervention: 0.9% saline (placebo block)
Number of subjects: 83
Study: 23224706

Group type: EXPERIMENTAL
Intervention: 6-month outpatient exercise-based cardiac rehabilitation programme (group T)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Generic instructions for maintaining physical activity and correct lifestyle (group C)
Number of subjects: 46
Study: 21645443

Group type: EXPERIMENTAL
Intervention: PRFA+PEI therapy group
Number of subjects: 75

Group type: COMPARATOR
Intervention: PRFA control group
Number of subjects: 75
Study: 18422519

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg sublingually
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Fentanyl 0.05 mg intravenously
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Fentanyl 0.1 mg intravenously
Number of subjects: 276

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 276
Study: 16598319

Group type: EXPERIMENTAL
Intervention: Vitamin E (600 mg/day) for one month
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg twice daily) for one month
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Vitamin E (600 mg/day) and Gemfibrozil (600 mg twice daily) combined for one month
Number of subjects: 99
Study: 12902212

Group type: EXPERIMENTAL
Intervention: Risperidone (2-8 mg per day; mean dose=4.15±0.4 mg per day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 20
Study: 10768903

Group type: EXPERIMENTAL
Intervention: Three dimensional echocardiography
Number of subjects: 30

Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 30
Study: 9151591

Group type: EXPERIMENTAL
Intervention: Immediate transmucosal implants with guided tissue regeneration
Number of subjects: 41

Group type: COMPARATOR
Intervention: Immediate implants without guided tissue regeneration (Control group 1)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard procedure implants (Control group 2)
Number of subjects: 41
Study: 1331020

Group type: EXPERIMENTAL
Intervention: Temafloxacin 600 mg every 12 h for 7-14 days
Number of subjects: 564

Group type: COMPARATOR
Intervention: Ciprofloxacin 750 mg every 12 h for 7-14 days
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Temafloxacin
Number of subjects: 564

Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 564

Group type: COMPARATOR
Intervention: Ciprofloxacin with concomitant theophylline
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Temafloxacin with concomitant theophylline
Number of subjects: 564
Study: 3805302

Group type: EXPERIMENTAL
Intervention: Mini-Mult
Number of subjects: 60

Group type: COMPARATOR
Intervention: MMPI
Number of subjects: 60
Study: 30230245

Group type: EXPERIMENTAL
Intervention: 3D printed models during lectures
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard lecture with 2D images
Number of subjects: 60
Study: 27987510

Group type: EXPERIMENTAL
Intervention: Shaping DLT with tracheal orifice aligned with the concave aspect of the distal curvature (group U)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Shaping DLT with tracheal orifice aligned with the convex aspect of the distal curvature (group T)
Number of subjects: 136
Study: 24835519

Group type: EXPERIMENTAL
Intervention: Unplanned GP visits
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Planned GP visits
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Advice for unplanned visits
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Advice for planned visits
Number of subjects: 150
Study: 22662602

Group type: EXPERIMENTAL
Intervention: Intravenous Ceftazidime within 60 minutes prior to surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous placebo (10 ml isotonic sodium chloride 0.9% solution)
Number of subjects: 200
Study: 19659505

Group type: EXPERIMENTAL
Intervention: Office care temporary denture reliners (OR)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Home care temporary denture reliners (HR)
Number of subjects: 34
Study: 18355134

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% once-daily in the evening
Number of subjects: 20

Group type: COMPARATOR
Intervention: Timolol maleate 0.5% in Gelrite once-daily in the morning
Number of subjects: 20
Study: 16918588

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg) plus rosiglitazone (2 mg), administered as one capsule twice daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 200
Study: 12962761

Group type: EXPERIMENTAL
Intervention: Corticosteroids + CsA
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Corticosteroids + CsA + Basiliximab
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Corticosteroids + Tacrolimus + Basiliximab
Number of subjects: 95
Study: 10758071

Group type: EXPERIMENTAL
Intervention: Exposure therapy alone or in combination with sertraline
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 45
Study: 8690565

Group type: EXPERIMENTAL
Intervention: Neonatal ECMO
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study: 1432554

Group type: EXPERIMENTAL
Intervention: Oro-naso-pharyngeal suction (S Group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No oro-naso-pharyngeal suction (NS Group)
Number of subjects: 40
Study: 3883559

Group type: EXPERIMENTAL
Intervention: Intravenous fluid regimen with 3.5% amino acids, 20% fat, and 2.5% glucose
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous fluid regimen with 3.5% amino acids and 20% fat alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12
Study: 31790905

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy (statins, ezetimibe)
Number of subjects: 11066

Group type: EXPERIMENTAL
Intervention: Each 10 mg/dL higher LDL-C value
Number of subjects: 11066
Study: 28481434

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 50 or 70 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23418932

Group type: EXPERIMENTAL
Intervention: System of care delivered by stroke care coordinators
Number of subjects: 800

Group type: COMPARATOR
Intervention: Current practice in stroke services (Control)
Number of subjects: 800
Study: 23265919

Group type: EXPERIMENTAL
Intervention: SystemCHANGE-HIV intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 21319354

Group type: EXPERIMENTAL
Intervention: Propofol combined with low dose fentanyl (PF group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Midazolam combined with low dose fentanyl (MF group)
Number of subjects: 32